Hypothyroidism: initiation of replacement therapy
- Autores: Morgunova T.B.1, Fadeev V.V.1
-
Afiliações:
- I.M. Sechenov First Moscow state medical university
- Edição: Nº 6 (2016)
- Páginas: 68-70
- Seção: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/277760
- ID: 277760
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Primary hypothyroidism is one of the most common endocrine diseases. Treatment of symptomatic hypothyroidism involves the appointment of replacement monotherapy with levothyroxine that maintains the disease compensation. The article discusses the issue of initiation of replacement therapy of hypothyroidism for different groups of patients.
Palavras-chave
Texto integral
Sobre autores
Tatiana Morgunova
I.M. Sechenov First Moscow state medical universityPhD, Department of endocrinology
Valentin Fadeev
I.M. Sechenov First Moscow state medical university
Email: walfad@mail.ru
corresponding member of RAS, MD, professor, head of the Department of endocrinology
Bibliografia
- Jonklaas J., Bianco A.C., Bauer A.J., Burman K.D., Cappola A.R., Celi F.S., Cooper D.S., Kim B.W., Peeters R.P., Rosenthal M.S., Sawka A.M. Guidelines for the treatment of hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-751.
- De Groot L., Abalovich M., Alexander E.K., Amino N., Barbour L., Cobin R.H., Eastman C.J., Lazarus J.H., Luton D., Mandel S.J., Mestman J., Rovet J., Sullivan S. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2012;97(8):2543-65.
- Roos A., Linn-Rasker S.P., van Domburg R.T., Tijssen J.P., Berghout A. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch. Intern. Med. 2005;165(15):1714-20.
- Biondi B., Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine. 2004;24:1-13.
- Cappola A.R., Ladenson P.W. Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 2003;88:2438-44.
- Delemer B., Aubert J.P., Nys P., Landron F., Bouée S. An observational study of the initial management of hypothyroidism in France: the ORCHIDÉE study. Eur. J. Endocrinol. 2012;167(6):817-23.
- Schifferdecker E., Balz F., Jungmann E., Schoffling K. Compliance problems in therapy with levothyroxine. Med. Klin (Munich). 1990;85(8):477-80.
- Sevinc A., Savli H. Hypothyroidism masquerading as depression: the role of noncompliance. J. Natl. Med. Assoc. 2004;96(3):379-82.
- Burnett J.R., Cooke R., Crooke M.J., Feek C.M. A study of L-thyroxine replacement. N. Z. Med. J. 1992;105(930):105-6.
- Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 2000;160(4):526-34.
Arquivos suplementares
